Market Analysis and Price Projections for NDC 60687-0630: Nabumetone
Introduction
Nabumetone, identified by the National Drug Code (NDC) 60687-0630, is a nonsteroidal anti-inflammatory drug (NSAID) manufactured and distributed by American Health Packaging. This analysis will delve into the current market dynamics, pricing trends, and future projections for this medication.
Current Market Dynamics
Manufacturer and Distribution
Nabumetone, under the NDC 60687-0630, is produced by American Health Packaging, a company known for its extensive portfolio of pharmaceutical products. The distribution network of American Health Packaging ensures widespread availability of Nabumetone across various healthcare settings[5].
Therapeutic Use
Nabumetone is used to treat pain, inflammation, and stiffness caused by osteoarthritis and rheumatoid arthritis. Its efficacy in managing chronic pain makes it a staple in many treatment regimens.
Pricing Trends
Historical Pricing
While specific historical pricing data for NDC 60687-0630 is not readily available, general trends in the pharmaceutical industry can provide insights. Drug prices have been a subject of significant concern due to their impact on patient affordability and healthcare costs. For instance, many drugs have seen price increases ranging from 20 to 55 percent between 2018 and 2023[2].
Current Pricing
For other drugs manufactured by American Health Packaging, pricing can vary based on the vendor, packaging, and pricing type. For example, Colchicine (NDC 60687-0358) has seen prices fluctuate, with recent prices around $2.53 per unit[1]. While this does not directly reflect Nabumetone's pricing, it indicates the variability and potential for price adjustments.
Future Price Projections
Overall Pharmaceutical Market Trends
The pharmacy market outlook for 2025 suggests a stable to slightly increasing trend in drug prices. However, the overall projected drug price inflation rate for 2025 is expected to be around 0.00%, indicating a relatively stable pricing environment[4].
Impact of Generic and Biosimilar Competition
The life sciences industry is facing increased competition from generic drugs and biosimilars, which can drive prices down. Nearly 37% of surveyed executives view competition from these alternatives as a significant trend, which could influence the pricing strategy for Nabumetone[3].
Regulatory and Negotiation Efforts
Beginning in January 2026, Medicare’s negotiated prices for certain drugs will come into effect, resulting in discounts ranging from 38% to 79% compared to list prices. While Nabumetone is not specifically mentioned in these negotiations, such regulatory efforts can set precedents for broader price reductions in the pharmaceutical market[2].
Key Factors Influencing Pricing
Patent Expiration and Market Exclusivity
The biopharma industry is facing a substantial loss of exclusivity due to expiring patents, which could impact the pricing of drugs like Nabumetone. However, since Nabumetone is already a generic medication, its pricing is less likely to be affected by patent expirations[3].
Digital Transformation and Innovation
The integration of technologies like gen AI and increased use of data are expected to boost operational efficiencies and drive innovations. These advancements could lead to more efficient production and distribution, potentially stabilizing or reducing prices[3].
Conclusion
The market analysis for Nabumetone (NDC 60687-0630) indicates a stable pricing environment in the short term, influenced by broader pharmaceutical market trends. Here are some key takeaways:
- Stable Pricing Environment: The projected 0.00% drug price inflation rate for 2025 suggests that prices for Nabumetone are likely to remain stable.
- Competition from Generics and Biosimilars: Increased competition could drive prices down, but since Nabumetone is already a generic, this impact may be minimal.
- Regulatory Efforts: Medicare’s negotiated prices and other regulatory efforts could set a precedent for broader price reductions, but their direct impact on Nabumetone is uncertain.
- Technological Advancements: Improved operational efficiencies through digital transformation could stabilize or reduce prices in the long term.
Key Takeaways
- Market Stability: The pharmaceutical market is expected to see stable prices in 2025.
- Competition: Generic and biosimilar competition may influence pricing strategies.
- Regulatory Impact: Medicare’s negotiated prices could set a precedent for future price reductions.
- Technological Advancements: Digital transformation and innovation are expected to improve operational efficiencies.
- Patient Affordability: Stable or reduced prices can improve patient affordability and access to medications.
FAQs
-
What is Nabumetone used for?
- Nabumetone is used to treat pain, inflammation, and stiffness caused by osteoarthritis and rheumatoid arthritis.
-
Who manufactures Nabumetone under NDC 60687-0630?
- Nabumetone under NDC 60687-0630 is manufactured by American Health Packaging.
-
What are the projected price trends for pharmaceuticals in 2025?
- The projected overall drug price inflation rate for 2025 is expected to be around 0.00%, indicating a relatively stable pricing environment.
-
How does competition from generics and biosimilars affect drug prices?
- Competition from generics and biosimilars can drive prices down as they offer cheaper alternatives to branded drugs.
-
What impact do regulatory efforts have on drug pricing?
- Regulatory efforts, such as Medicare’s negotiated prices, can result in significant discounts and set precedents for broader price reductions in the pharmaceutical market.
Sources
- DrugPatentWatch - Latest drug prices and trends for NDC 60687-0358.
- ASPE - HHS.gov - Medicare Drug Price Negotiation Program.
- Deloitte Insights - 2025 life sciences outlook.
- Vizient Inc. - Pharmacy Market Outlook Summer 2024.
- FindACode - American Health Packaging - NDC Labeler/Manufacturer.
